Search

Author/Creator Thijs, Judith

3. Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients. Issue 2 (22nd December 2022)

Authors:
Achten, Roselie; Thijs, Judith; van Luijk, Chantal; Knol, Edward; Delemarre, Eveline; de Graaf, Marlies; Bakker, Daphne; de Boer, Joke; van Wijk, Femke; de Bruin‐Weller, Marjolein
Journal:
Clinical & experimental allergy
Issue:
Volume 53:Issue 2(2023)
Page Start:
239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Issue 1 (16th January 2023)

Authors:
Achten, Roselie; Thijs, Judith; van der Wal, Marlot; van Luijk, Chantal; van Luin, Matthijs; el Amrani, Mohsin; Knol, Edward; Delemarre, Eveline; Jager, Constance den Hartog; de Graaf, Marlies; Bakker, Daphne; de Boer, Joke; van Wijk, Femke; de Bruin‐Weller, Marjolein
Journal:
Clinical and translational allergy
Issue:
Volume 13:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Issue 11 (29th July 2022)

Authors:
Spekhorst, Lotte S.; Bakker, Daphne; Drylewicz, Julia; Rispens, Theo; Loeff, Floris; Boesjes, Celeste M.; Thijs, Judith; Romeijn, Geertruida L. E.; Loman, Laura; Schuttelaar, Marie‐Louise; van Wijk, Femke; de Graaf, Marlies; de Bruin‐Weller, Marjolein S.
Journal:
Allergy
Issue:
Volume 77:Issue 11(2022)
Page Start:
3398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗